Middle East And Africa Human Insulin Market Share

Statistics for the 2023 & 2024 Middle East And Africa Human Insulin market share, created by Mordor Intelligence™ Industry Reports. Middle East And Africa Human Insulin share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Middle East And Africa Human Insulin Industry

The Middle-East and Africa human insulin market is dominated by Novo Nordisk, Sanofi, and Eli Lilly. However, there are many local players like Biocon, Julphar, Sedico, and Exir, who hold a significant market share.

Middle East and Africa Diabetes Treatment Market Leaders

  1. Novo Nordisk

  2. Sanofi

  3. Eli lilly

  4. Wockhardt

  5. Pfizer

*Disclaimer: Major Players sorted in no particular order

Middle East and Africa Human Insulin Market Concentration

Middle East and Africa Diabetes Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)